Immix Biopharma files updated auditor consents for S-3 registration

Immix Biopharma, Inc.

Filed updated consents from former auditor KMJ Corbin and current auditor Crowe LLP, dated Nov 26, 2025.
Consents relate to audit reports on FY2024 financials included in Form 10-K filed Mar 25, 2025.
Consents are for incorporation into Registration Statement on Form S-3 (No. 333-290725).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.